Oxford Biomedica Plc (OXBDF)
6.65
0.00 (0.00%)
USD |
OTCM |
Oct 01, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 804.69M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -15.88% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 3.416 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 90.85% |
Profile
| Oxford Biomedica Plc engages in the provision of contract development and manufacturing services for cell and gene therapy products. It provides viral vector development and manufacturing services, including lentiviral vector, adeno-associated virus, adenovirus, and other viral vector technologies, as well as development, procurement, and related services.The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.oxb.com |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Core |
| Next Earnings Release | Mar. 25, 2027 (est.) |
| Last Earnings Release | Sep. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Oxford Biomedica Plc engages in the provision of contract development and manufacturing services for cell and gene therapy products. It provides viral vector development and manufacturing services, including lentiviral vector, adeno-associated virus, adenovirus, and other viral vector technologies, as well as development, procurement, and related services.The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom. |
| URL | http://www.oxb.com |
| Investor Relations URL | N/A |
| HQ State/Province | Oxfordshire |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Core |
| Next Earnings Release | Mar. 25, 2027 (est.) |
| Last Earnings Release | Sep. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |